$2.58
-0.05-1.90%
At close: -
$2.57
-0.01-0.39%
After Hours: Jan 21, 4:16 PM EDT
Comments
Loading...
CASI Pharmaceuticals (NASDAQ:CASI) Stock, Earnings Estimates, EPS, And Revenue
CASI Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 27
EPS Estimate
$0.000
Quarterly Revenue Estimate
$7.39M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$22.05M
Analyze the earnings history of CASI Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
CASI Pharmaceuticals (CASI) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-15 | $-0.55 | $-0.62 | 11.3 % |
| Q2 | 2024-08-16 | $-0.52 | $-0.63 | 17.5 % |
| Q1 | 2024-05-14 | $-0.71 | $-0.05 | -1320.0 % |
| Q4 | 2024-03-28 | $-0.45 | $-0.24 | -87.5 % |
CASI Pharmaceuticals (CASI) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-15 | $7.79M | $4.56M | 70.9 % |
| Q2 | 2024-08-16 | $3.98M | $4.43M | -10.2 % |
| Q1 | 2024-05-14 | $3.41M | $12.00M | -71.6 % |
| Q4 | 2024-03-28 | $6.87M | $9.41M | -27.0 % |
FAQ
When is CASI Pharmaceuticals (NASDAQ:CASI) reporting earnings?
CASI Pharmaceuticals (CASI) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on November 15, 2024 for Q3.
What were the latest earnings per share (EPS) for CASI Pharmaceuticals (NASDAQ:CASI)?
The Actual EPS was $-0.55, which beat the estimate of $-0.62.
What were CASI Pharmaceuticals’s (NASDAQ:CASI) revenues?
The Actual Revenue was $7.8M, which beat the estimate of $4.6M.
Browse earnings estimates, EPS, and revenue on all stocks.